Clinical Trials on Prostatic Neoplasms in New Zealand

Total 16889 results

Weill Medical College of Cornell University
Viewray Inc.

Active, not recruiting

Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks

Prostate Cancer

United States
NYU Langone Health
United States Department of Defense

Completed

Randomized Trial of Trust in Online Videos About Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University; Broad Institute

Completed

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

Prostate Cancer

United States
Icahn School of Medicine at Mount Sinai

Terminated

CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation

Prostate Cancer

United States
NYU Langone Health
New York State Department of Health

Completed

Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Magnetic Resonance Imaging and Spectroscopy of the Prostate

Prostate Cancer

United States
Clarity Pharmaceuticals Ltd

Completed

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA) (COBRA)

Biochemical Recurrence of Malignant Neoplasm of Prostate

United States
SonaCare Medical

Unknown

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial) (STAR)

Recurrent Prostate Cancer

United States, Canada
Harbor Therapeutics

Completed

A Phase I/II Study of HE3235 in Patients With Prostate Cancer

Prostate Cancer

United States
NYU Langone Health

Completed

Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development

Prostate Cancer | Bladder Cancer

United States
Bavarian Nordic

Completed

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer (Prospect)

Prostate Cancer Metastatic

United States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
Memorial Sloan Kettering Cancer Center

Recruiting

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

Prostate Cancer

United States
GlaxoSmithKline

Completed

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk (REDUCE)

Neoplasms, Prostate

United States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
Active Biotech AB

Completed

Efficacy Study of ABR-215050 to Treat Prostate Cancer

Prostate Cancer

United States, Canada, Sweden
Weill Medical College of Cornell University

Recruiting

Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) (RTIRE)

Prostate Cancer

United States
Weill Medical College of Cornell University

Active, not recruiting

PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) (PREPARE SBRT)

Prostate Cancer

United States
Icahn School of Medicine at Mount Sinai

Active, not recruiting

Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer

Prostate Cancer

United States
Icahn School of Medicine at Mount Sinai
Sanofi; Bayer

Completed

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Aragon Pharmaceuticals, Inc.

Completed

ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate

Prostate Cancer

United States
Exelixis

Terminated

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer (COMET-2)

Pain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate Cancer

United States, Canada, Australia, United Kingdom, Ireland
National Cancer Institute (NCI)

Completed

Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Hormone-refractory Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Copanlisib in Combination With Degarelix in People With Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer

Prostate Cancer

United States
SOTIO a.s.

Completed

Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (VIABLE)

Metastatic Castration-resistant Prostate Cancer

United States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
Progenics Pharmaceuticals, Inc.

Completed

A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Boston Scientific Corporation
Augmenix, Inc.

Completed

SpaceOAR System Pivotal Study

Prostate Cancer

United States
Ferring Pharmaceuticals

Completed

A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

Prostate Cancer

India
IsoRay Medical, Inc.
Swedish Medical Center

Withdrawn

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Prostate Cancer

United States
Weill Medical College of Cornell University

Completed

Use of Multiphoton Microscopy in the Diagnosis of Cancer (MPM)

Prostate Cancer | Bladder Cancer

United States
Janssen Scientific Affairs, LLC

Completed

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability (REAAcT)

Prostate Cancer

United States
Agennix

Completed

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

Prostate Cancer | Hormone Refractory Prostate Cancer

United States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
Centocor, Inc.

Terminated

A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)

Cancer, Prostate

United States, United Kingdom, Belgium, Germany, Spain, France, Austria
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Columbia University; Duke University; Lithuanian University... and other collaborators

Completed

A Registry for Patients Treated on the Clinical Trial TAX 3503

Prostate Cancer

United States, Canada, Lithuania
Myriad Genetic Laboratories, Inc.

Completed

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing (URO-009Low)

Prostate Cancer

United States
LTN PHARMACEUTICALS, INC.

Completed

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer (ARMOR1)

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Ferring Pharmaceuticals

Active, not recruiting

Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy

Metastatic Castration Sensitive Prostate Cancer

United States
Curium US LLC

Recruiting

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur)

Prostate Cancer | Prostate Adenocarcinoma | Biochemical Recurrence of Malignant Neoplasm of Prostate

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Novartis; Prostate Cancer Clinical Trials Consortium

Completed

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7 | Prostate Carcinoma Metastatic in the Bone

United States
Memorial Sloan Kettering Cancer Center

Completed

Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers

Head and Neck Cancer | Prostate Cancer

United States
Orion Corporation, Orion Pharma
Endo Pharmaceuticals

Completed

Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer

Prostate Cancer

United States, United Kingdom, Finland, France, Czech Republic, Estonia
Weill Medical College of Cornell University

Terminated

A Prospective Trial on Nerve Sparing Techniques Performed in Radical Prostatectomy

Quality of Life | Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Prostate Cancer

United States
Veru Inc.

Terminated

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent (VERACITY)

Metastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Prostate Cancer

United States
Tyler J Curiel

Not yet recruiting

Telmisartan in Prostate Cancer

Prostate Cancer

United States
Ryan J. Halter
Dartmouth College

Recruiting

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment (RARP EI)

Prostate Cancer

United States

Clinical Trials on Prostatic Neoplasms in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations